ANDREW DRANCHAK: Open Payments
NPI 1104436161 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 12 payments from 5 companies in 2025. Trend: 2023 $313 · 2024 $575 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 8 | $207 |
| Janssen Pharmaceuticals, Inc | 1 | $150 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $16 |
Products named: INGREZZA, INVEGA SUSTENNA, REXULTI, FANAPT, Auvelity.
Industry payments across IN — which companies pay providers there.
